Joao Cavalcante is a Cardiology physician affiliated with Abbott Northwestern Hospital. OpenAlex indexes 494 publications with 9,997 citations (h-index 52); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 E 28th St Ste H2100
Minneapolis, MN 554073723
Telephone
612-863-3900Provider last certified this registry record 5 Jan 2024.
Clinical trials
- Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
Sponsor: Minneapolis Heart Institute Foundation
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year202551 payments$61,230openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202515 payments$12,188openpaymentsdata.cms.gov ↗
- Edwards Lifesciences CorporationProgram year202518 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
60.1%Statin23.3%Rosuvastatin Calcium81%Atorvastatin Calcium20%Part D≥73 patientsBeta blocker8.5%Metoprolol Succinate69%Carvedilol16%Metoprolol Tartrate15%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
28.7%SGLT2 inhibitor23.8%Jardiance52%Farxiga48%Part D≥38 patientsGLP-1 receptor agonist4.8%Mounjaro41%Ozempic33%Wegovy27%Part D<11 patientsBlood & clotting
11.2%Factor Xa inhibitor9.5%Eliquis83%Xarelto17%Part D<11 patientsP2Y12 inhibitor1.8%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure
JACC: Cardiovascular Interventions
2023 - Multi-modality imaging in aortic stenosis: an EACVI clinical consensus document
European Heart Journal - Cardiovascular Imaging
2023 - Diagnosis, Classification, and Management Strategies for Mitral Annular Calcification
JACC: Cardiovascular Interventions
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Amr Idris, MD
Abbott Northwestern Hospital
Michael Miedema, MD
Abbott Northwestern Hospital
Erik Schelbert, MD
Abbott Northwestern Hospital
Vinayak Bapat, MD
Abbott Northwestern Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”